Lung cancer
Conditions
Interventions
General anesthesia group:General anesthesia(inducted with sufentanil 5ug/kg+etomidate 2mg/kg + cisatriptan 2mg/kg,maintained with propofol 2.5ug/ml+remifentanil 3 ng/ml)
Control group:Ropivacaine 10ml ultrasound guided for T5 vertebral nerve block (after induction, before surgery)
Dexmedetomedine group:Dexmedetomedine 1.0ug/kg+0.5% ropivacaine 10ml ultrasound guided for T5 vertebral nerve block (after induction, before surgery)
Sponsors
Suzhou Science & Technology Town Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients who planned to accept Unilateral thoracoscopic lobectomy under general anesthesia; 2. aged 18-65 years; 3. ASA grade I-III; 4. without cardiac or pulmonary diseases such as sinoatrial bradycardia, Functional lesions of sinus node or severe arrhythmia, without chest deformity; 5. Patients themselves and whose relatives who are fully aware of this study and agree to take part.
Exclusion criteria
Exclusion criteria: 1. Patients who have underwent or are undergoing other kinds of clinical trials; 2. according to the physicians judgement, patients who may suffer greater risk in this study or their data cannot be collected sufficiently should be excluded; 3. patients whose surgeries were finished under other kinds of anesthesia instead of general anesthesia or patients whose surgeries were changed to conventional thoracotomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS scale;Ramsay sedation score; | — |
Countries
China
Contacts
Public ContactWang Chen
Suzhou Science & Technology Town Hospital
Outcome results
None listed